AUSL-IRCCS di Reggio Emilia

The Azienda USL-IRCCS di Reggio Emilia integrates the province's public health services with the Arcispedale Santa Maria Nuova, which holds IRCCS status in 'advanced technologies and care models in oncology'. The cancer programme covers medical oncology, radiotherapy, haematology, surgical oncology, nuclear medicine and pathology, and is known for its work on care organisation and outcomes research, cancer registries and screening evaluation as well as translational research in lymphoma and breast cancer. It is accredited by the Organisation of European Cancer Institutes as a Comprehensive Cancer Centre.

Location

Reggio Emilia, IT

Type

hospital

Website

www.ausl.re.it

Newsweek 2026 oncology rank

Not in top 300 listing used

OnCo score

#569 · 4 points (0 Newsweek + 0 NCI + 4 from 2 linked objects) · ranking

Research output

From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.

Matched to Ospedale Santa Maria, including child institutions. 144 works · 583 citations · 76% open access · 19% clinical trials · 1% reviews.

Oncology works per year

272022

352023

242024

312025

272026

Most works

Most cited

Work	Journal	Year	Citations
Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine 10.3390/cancers15020416 · open access	Cancers	2023	44
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 10.1016/j.ijantimicag.2023.106806 · open access	International Journal of Antimicrobial Agents	2023	38
Glofitamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma: Extended Follow-Up from a Pivotal Phase II Study and Subgroup Analyses in Patients with Prior Chimeric Antigen Receptor T-Cell Therapy and by Baseline Total Metabolic Tumor Volume conference abstract · 10.1182/blood-2023-173951	Blood	2023	34
LBA45 Randomized open label phase III study comparing the efficacy and safety of everolimus followed by chemotherapy (CT) with streptozotocin (STZ)-5FU upon progression or the reverse sequence, in advanced progressive panNETs: The SEQTOR study (GETNE 1206) 10.1016/j.annonc.2022.08.044 · open access	Annals of Oncology	2022	31
Glofitamab Plus R-CHOP Induces High Response Rates with a Manageable Safety Profile in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A 12-Month Analysis from a Phase Ib Study conference abstract · 10.1182/blood-2023-174081	Blood	2023	28
Glofitamab Plus R-CHOP Induces High Response Rates and a Favorable Safety Profile in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results from a Phase Ib Study 10.1182/blood-2022-157732	Blood	2022	23
Amelanotic/hypomelanotic lentigo maligna: Dermoscopic and confocal features predicting diagnosis 10.1111/jdv.18636 · open access	Journal of the European Academy of Dermatology and Venereology	2022	19
Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) 10.1007/s00277-022-04884-x · open access	Annals of Hematology	2022	18
Clinical, histopathological and molecular features of dedifferentiated melanomas: An EORTC Melanoma Group Retrospective Analysis 10.1016/j.ejca.2023.03.032 · open access	European Journal of Cancer	2023	17
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer 10.1038/s41523-023-00579-2 · open access	npj Breast Cancer	2023	16
Incidence and prognosis of cutaneous melanoma in European adolescents and young adults (AYAs): EUROCARE-6 retrospective cohort results 10.1016/j.ejca.2024.115079 · open access	European Journal of Cancer	2024	14
The role of inflammation in acute coronary syndrome: A systematic review on biochemical inflammatory assessment and anti-inflammatory therapies review · 10.1016/j.numecd.2025.104409 · open access	Nutrition Metabolism and Cardiovascular Diseases	2025	13
Autoimmune Lymphoproliferative Syndrome (ALPS) Disease and ALPS Phenotype: Are They Two Distinct Entities? 10.1097/hs9.0000000000000845 · open access	HemaSphere	2023	13
723O Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients: Final results of the PEGASUS trial 10.1016/j.annonc.2025.08.1298 · open access	Annals of Oncology	2025	11
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities 10.1016/j.xcrm.2025.102029 · open access	Cell Reports Medicine	2025	11

Programmes

3top

Care models and outcomes research
Radiotherapy
Lymphoma and breast cancer research

People

1top

Davide Fornaciari

Direttore Generale, Azienda USL-IRCCS di Reggio Emilia

Public health administrationHospital management

Director general who leads the Azienda USL-IRCCS di Reggio Emilia, the health authority that runs the Arcispedale Santa Maria Nuova and its oncology research institute.

Connected

3top

Institution
ASST Spedali Civili di Brescia
Shares Mediterranean Institute of Oncology (IOM), Organisation of European Cancer Institutes and the tags oeci-accredited, oeci-comprehensive-cancer-centre.
Institution
Centro di Riferimento Oncologico di Aviano (CRO)
Shares Organisation of European Cancer Institutes and the tags oeci-accredited, oeci-comprehensive-cancer-centre, irccs.
Institution
IRCCS Ospedale Policlinico San Martino
Shares Organisation of European Cancer Institutes and the tags oeci-accredited, oeci-comprehensive-cancer-centre, irccs.
Person
Roberto Cunsolo
Shares Mediterranean Institute of Oncology (IOM), Organisation of European Cancer Institutes.
Institution
Hospital Universitario Fundación Jiménez Díaz
Shares Organisation of European Cancer Institutes and the tags oeci-accredited, oeci-comprehensive-cancer-centre.
Institution
University Medical Center Groningen Comprehensive Cancer Center
Shares Organisation of European Cancer Institutes and the tags oeci-accredited, oeci-comprehensive-cancer-centre.
Institution
Trinity St James's Cancer Institute
Shares Organisation of European Cancer Institutes and the tags oeci-accredited, oeci-comprehensive-cancer-centre.
Institution
Institut du Cancer Paris CARPEM, AP-HP Centre
Shares Organisation of European Cancer Institutes and the tags oeci-accredited, oeci-comprehensive-cancer-centre.

institutions

Mediterranean Institute of Oncology (IOM)Organisation of European Cancer Institutes

people

Davide Fornaciari

Research output

Programmes

People

Connected

Similar pages

institutions

people

AUSL-IRCCS di Reggio Emilia

Research output

Programmes

People

Connected

Similar pages

institutions

people

AUSL-IRCCS di Reggio Emilia

Overview

Research output

Programmes

People

Connected

Similar pages

institutions

people

AUSL-IRCCS di Reggio Emilia

Overview

Research output

Programmes

People

Connected

Similar pages

institutions

people